The majority of the included studies involved patients of all BC subtypes; thirteen reported risk factors for BM in HER2-positive patients [17, 20, 23–27, 44, 47, 61, 66, 80, 81] and three in TNBC patients [24, 39, 71]. The gene discussed is ERBB2; the disease is breast cancer.